A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to ... pointing to yet another potential use for the versatile drug class. The small, 48-subject study – published in the journal ...

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as GLP-1 receptor agonists soared nearly 600% between 2020 and 2023 in people ...

GLP-1 drugs like Ozempic and Wegovy revolutionized weight loss, but their high cost keeps them out of reach for most ...

Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders of pregnancy, gestational diabetes, have a preterm birth or cesarean ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

If you've been around long enough, you will encounter some bumps in the road. This is true for The Hershey Company ( HSY ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...